|
Page 10
910 F.2d 10
Fed. Sec. L. Rep. P 95,389
Irving A. BACKMAN, et al.,
Plaintiffs, Appellees,
v.
POLAROID CORPORATION, Defendant, Appellant.
Irving A. BACKMAN, et al., Plaintiffs,
Appellants,
v.
POLAROID CORPORATION, Defendant, Appellee.
Nos. 89-1171, 89-1172. United States Court of Appeals,
First Circuit. Reheard May 9, 1990.
Decided Aug. 2, 1990.
Page 11
John R. Hupper, with whom
Frederick A.O. Schwarz, Jr., James L.
Buchal, David E. Sternberg, Cravath, Swaine
& Moore, James E. Tolan, William K. Dodds,
Rodney M. Zerbe, Olwine, Connelly, Chase,
O'Donnell & Weyher, Stephen D. Poss and
Goodwin, Procter & Hoar, were on brief, for
Polaroid Corp.
Thomas J. Dougherty, Skadden,
Arps, Slate, Meagher & Flom, Patrick W.
Hanifin and New England Legal Foundation, on
brief, for Associated Industries of Mass.
and the New England Foundation, amici
curiae.
Stanley Keller and Palmer &
Dodge, on brief, for Business Law Section of
Boston Bar Ass'n, amici curiae.
John D. Donovan, Jr., Mark P.
Szpak and Ropes and Gray, on brief, for New
England Corporate Counsel Ass'n and American
Corporate Counsel Ass'n (Northeast Chapter),
amici curiae.
Thomas G. Shapiro, with whom
Carolyn Grace, Shapiro, Grace & Haber,
Richard B. Dannenberg, David C. Harrison,
Lowey, Dannenberg, Bemporad, Brachtl &
Selinger, P.C., Ronald Litowitz, Bernstein
Litowitz Berger & Grossmann, Arthur N.
Abbey, and Abbey & Ellis, were on brief, for
Irving A. Backman, et al.
Before BREYER, Chief Judge,
ALDRICH, Senior Circuit Judge, CAMPBELL,
Circuit Judge, BOWNES, Senior Circuit Judge,
TORRUELLA, SELYA and CYR, Circuit Judges.
BAILEY ALDRICH, Senior Circuit
Judge.
This is a class action brought by
Irving A. Backman on behalf of himself and
all other persons who purchased shares of
stock of defendant Polaroid Corporation on
the open market between January 11 and
February 22, 1979, allegedly misled by
defendant's conduct that violated Section
10(b) of the Securities Exchange Act of 1934
and Rule 10b-5 of the regulations
promulgated thereunder. Suit was filed in
June, 1979. The case came on for trial, on a
second amended complaint, in June, 1987, by
which time the docket showed 363 entries.
The improprieties asserted, both in the
complaint and in plaintiffs' opening to the
jury, as responsible for plaintiffs'
purchasing shares before a substantial drop
in the market, were defendant's failure to
disclose
Page 12 unfavorable facts about its new product,
Polavision, an instant movie camera.
Following trial on liability, the jury found
for plaintiffs. Defendant moved for judgment
n.o.v., or, alternatively, for a new trial,
but the court denied both motions. On
appeal, a divided panel affirmed as to the
former, but granted a new trial. On this
rehearing en banc we reverse, and order
judgment for defendant.
THE FACTS AND THE LAW: PHASE ONE
While we have been surprised
before, we have never been so reminded that,
no matter how fully expressed, our opinions
do not always command response. In their
amended complaint plaintiffs alleged that
defendant failed to disclose that
Polavision, introduced in the spring, had
been unprofitable throughout 1978, and would
continue so, significantly, at least through
1979; that it had been excessively
inventoried and had suffered lagging sales;
that little, if any, information had been
made public; that defendant knew that this
undisclosed information was material to
investors, and that major investment
research firms had publicly projected
defendant's earnings based on assumptions
defendant knew were contrary to the true
facts, all of which non-disclosure was in
violation of the securities laws.
Secondly, plaintiffs re-alleged
the above, and added that over the years
defendant had advertised that it was a
growth company, and that, through its
successes, the investment community had come
to consider it the best of the growth
companies, and that its failing to make the
above disclosures operated as a fraud and
deceit on the investing public, was a "fraud
on the market," and constituted an unlawful
manipulation thereof.
Defendant moved to dismiss on the
ground that the complaint did not state a
cause of action. This motion was denied. We
have not reviewed the possible correctness
of that ruling as of that date, but later it
became clearly incorrect. In March, 1987,
three months before trial, we decided
Roeder v. Alpha Industries, Inc.,
814 F.2d 22 (1st Cir.1987). In that case officers
of the defendant bribed an employee of a
defense contractor in order to obtain a
subcontract. When it was learned that its
officers were about to be indicted,
defendant released that information to the
public. Plaintiff brought a class action on
behalf of himself and others who had
purchased stock on the market following the
bribery, but before the announcement,
claiming that its non-disclosure was a
violation of the securities laws. The
district court dismissed, holding that
although there was a duty to disclose
material facts, there were no material facts
to disclose until an indictment became
probable, and that, as to this, defendant
acted promptly. We affirmed, but rejected
the court's reasoning. Rather, the fact of
the bribery itself "reasonable investors
might have considered ... to be important
information they would want to have before
they made their investment decisions." 814
F.2d at 25. However, mere market interest is
no basis for imposing liability. We said, at
page 26,
The materiality of the information
claimed not to have been disclosed ... is
not enough to make out a sustainable claim
of securities fraud. Even if information is
material, there is no liability under Rule
10b-5 unless there is a duty to disclose it.
A duty to disclose "does not
arise from the mere possession of non-public
information."
Chiarella v. United States, 445 U.S. 222,
235, 100 S.Ct. 1108, 1118, 63 L.Ed.2d 348
(1980).
Continuing, at pages 27-28,
Roeder claims that a corporation has an
affirmative duty to disclose all material
information even if there is no insider
trading, no statute or regulation requiring
disclosure, and no inaccurate, incomplete,
or misleading prior disclosures. The
prevailing view, however, is that there is
no such affirmative duty of disclosure....
Roeder relies on the "fraud on
the market" theory, which has been employed
by a number of courts in nondisclosure
cases, for his argument that
Page 13 there is an affirmative duty to disclose
material information to the public. [cit.
omitted] Contrary to Roeder's claim, the
fraud on the market theory has nothing to do
with an affirmative duty to disclose
material information. It only addresses ...
reliance.... In every fraud on the market
case Roeder cites, there was a duty to
disclose because of misleading reports or
statements....
In sum, Roeder's complaint does
not allege facts that, if proved, would
establish Alpha had a duty to disclose the
alleged illegal payments.
It would seem difficult to find
language, or a holding, that more closely
tracked, and completely invalidated, both
aspects of plaintiffs' complaint.
Notwithstanding, in total disregard,
plaintiffs' opening, trespassing at length
on the court's own prerogative, informed the
jury that the law was that it could find an
unfulfilled duty to disclose if it found
that what defendant failed to disclose about
Polavision would have been material to the
investing public. 1
At the side bar, at the close of the
opening, defendant correctly pointed out
that there had been no indication that
defendant had traded in its own stock, or
had made a misrepresentation, or had
violated any reporting requirements, and
moved for a directed verdict pursuant to
Roeder, of which it had previously given the
court a copy. The court, unhappily, failed
to see that plaintiffs' case was dead on
arrival, and denied the motion without
comment.
Nor did Roeder stimulate
plaintiffs to change their tack, and meet
Roeder, by claiming "inaccurate, incomplete,
or misleading prior disclosures." Rather, in
a twelve day trial, they precisely followed
their opening, alleging, simply,
nondisclosure of material information. As
summarized in their final argument,
Polaroid ... violated the federal
securities laws which require full
disclosure so that people who purchase and
sell securities do so on a fair playing
field; that people have the same information
and people can make their investment
decisions based on having all of the
information and having truthful
information.... [Y]ou have to find that
Polaroid had adverse information, that
information was material--i.e., that it was
important--and that Polaroid knowingly and
deliberately withheld it. And that's all
we're asking you to do here. (Emphasis
supplied).
The summation was not an
inadvertence, but was in accord with
plaintiffs' own testimony.
Q. Now, Mr. Backman, in this action you
are not claiming, are you, that the
financial information put out by Polaroid
was in any way false and misleading, are
you?
A. I think you'll have to refer to the
complaint. I believe the failure to disclose
is just as improper as providing false
information. And I believe the essence of my
suit deals with the failure to disclose....
I do claim it was false and misleading
because the failure to disclose is just as
misleading a (sic) improper disclosure.
This, of course, is not so.
"Silence, absent a duty to disclose, is not
misleading under Rule 10b-5." Chiarella,
ante. 2
Page 14
Plaintiffs' summation was
followed by the court's charge, equally
contrary to Roeder. 3
TRANSITION
We have gone into this at length,
not so much to show the emptiness of
plaintiffs' first claim--agreed to by the
full panel--but to accent our finding that
there had been no falsity or misleading by
defendant in any respect. In eight years of
preparation and twelve days of trial, the
words misrepresentation and misleading never
crossed plaintiffs' lips, even when
challenged by defendant's citation of
Roeder, except to deny that they were
claimed. Surely in plaintiffs' four law
firms, there must have been someone who read
Roeder with dismay, and called attention to
the escape route. The inference seems
manifest that to shift to a claim of
misrepresentation and misleading seemed even
less hopeful than to stay where they were.
Finally facing up to the problem
of Roeder, plaintiffs, on defendant's appeal
to the panel, used these words thirty-two
times. "Polaroid's third quarter 1978 report
[issued in early November] contained
material misrepresentations...." "Polaroid's
representations in its third quarter report
were misleading in November, and blatantly
false by the end of Polavision's critical
Christmas season." These facts are so clear,
plaintiffs now tell us, "This rehearing
petition should never have been filed."
Before the panel, defendant
protested that this was a total variance.
Taking the position that on a motion for a
directed verdict the test is what the record
permitted, not what was claimed, the panel
opinion overruled the protest. Defendant now
seeks to renew what would seem, on this
record, a reasonable complaint. It is not
however, before us. Counsel's obligatory
certification accompanying the petition for
rehearing and suggestion for rehearing en
banc made no mention of it. Presumptively,
this was waiver.
Irvine v. California, 347 U.S. 128, 129, 74
S.Ct. 381, 381, 98 L.Ed. 561 (1954) ("We
disapprove of the process of smuggling
additional questions into the case after we
grant certiorari."). In its en banc brief
defendant devotes four pages to the alleged
impropriety of plaintiffs' "switching
theories" on appeal, and, correspondingly,
consumed a substantial portion of its
limited time for oral argument. Ironically,
if found justified, this would moot the
questions for which defendant had sought,
and we had granted, review. A party should
not address a petition to an important
question and then, after we have accepted
it, argue that it does not arise.
Particularly this should be so when the
petition has evoked a number of important
amici.
Equally not before us are the
findings and conclusions of the panel
majority opinion, hereinafter the panel
opinion. Plaintiffs frequently cite such,
sometimes as their sole authority. The
opinion "no longer [has] standing," except
to the extent that we adopt it.
United States v. Klubock, 832 F.2d 664, 665
(1st Cir.1987) (en banc). With one
exception, we do not respond to specific
assertions that we may disagree with, but
disregard the opinion altogether.
Correspondingly, we do not cite the dissent.
Page 15
THE FACTS AND THE LAW: PHASE TWO
Much of the trial was devoted to
matters that need not be considered. For
present purposes, it appeared that Dr. Edwin
H. Land, the founder and at all times
president or C.E.O. of Polaroid, had added
to his invention of the world-famous instant
still camera another exceptional
invention--an instant movie camera,
Polavision. It appeared throughout the case,
however, that Polavision's sales appeal did
not correspond with the quality of the
invention. Launched in early 1978 with great
fanfare, the estimates for fall, to which
production had been geared, proved to be
substantially excessive. As a result, in
late October, Eumig, the Austrian
manufacturer, having earlier been told to
increase production, was instructed to
reduce by 20,000. In mid-November Eumig was
told to take out another 90,000 sets, and to
halt production. Plaintiffs' panel brief,
quoting the fortuitous language of Eumig's
cable acknowledgement, "to now finally stop
production entirely," gives the impression
that the halt was intended to be permanent.
Conveniently, from plaintiffs' standpoint,
dots in the quotation replace the subsequent
sentence, "Steps have been taken to ensure a
quick new start-up of production on a
reduced scale." This omission aids
plaintiffs in their recitation, the
regrettable incorrectness of which we will
come to, that "management knew that
Polavision was a commercial failure."
Thereafter, fourth quarter internal figures,
not publicly released, confirmed that the
original Polavision estimates (also not
released) had been substantially excessive.
The next event was a newspaper
release published on January 9, 1979, that
Rowland Foundation, a charitable trust
established by Dr. and Mrs. Land, was to
sell 300,000 shares of Polaroid, in part for
funds for a new project, and in part to
diversify its portfolio. Defendant
participated in the preparation of the
release, but not in the action itself. It is
not claimed that the release was in any way
untrue. Plaintiffs' claim it misleading
because additional information should then
have been given the public. The sale was
consummated on January 11. For some reason,
never explained, plaintiffs take January 11,
rather than January 9, or the date of the
November report, as the day on which
fraudulently affected purchases began.
On February 22, 1979, immediately
following the annual meeting, defendant
announced further facts about Polavision's
lack of success, and the market fell,
shortly, by some 20%. In a separate trial on
damages, the jury found that plaintiff
purchasers' recovery should be $9.75 a
share. This matter is not before us. Further
facts will appear in the course of the
opinion.
1. Misrepresentation
By way of introduction we note
that while securities fraud is an exception
to the general rule that a party must show
reliance, it being presumed that the fraud
affected the market,
Basic, Inc. v. Levinson, 485 U.S. 224, 108
S.Ct. 978, 99 L.Ed.2d 194 (1988); see
Roeder, 814 F.2d at 27, it must be asked
what effect could there have been, on
anyone, of conduct not discovered to have
been misleading even by hostile examiners,
until, after eight years and completion of
trial, it was concluded that discovery of
such was necessary for recovery.
Starting with the Third Quarter
Report, that plaintiffs' brief now finds
assisted misrepresentation because "Polaroid
featured Polavision on the cover,"
plaintiffs point out that after President
McCune "announced record worldwide sales and
earnings for both the third quarter and the
first nine months of 1978, ... Mr. McCune
noted that the Company's worldwide
manufacturing facilities continue to operate
at close to maximum capacity," whereas, in
fact, Polavision's contract supplier, Eumig,
was told, shortly before the report, to hold
up on 20,000 units. We note, first, that the
statement, taken as a whole, was true; it
expressly recognized an absence of totality.
4
Page 16 Of more specific importance, it flagged, on
three of its three and a half pages of text,
that Polavision's effect on earnings was
negative. On page one, "He noted also that
earnings continue to reflect substantial
expenses associated with Polavision,
Polaroid's new system of instant movies."
This sentence was recast on the two
subsequent pages, "The ratio of cost of
sales to net sales increased ... due
primarily to ... and to substantial expenses
associated with Polavision." With this
emphasized three times, we ask did this
report mislead investors to buy stock
because Polavision was doing so well?
Plaintiffs quote Roeder, 814 F.2d
at 26, that even a voluntary disclosure of
information that a reasonable investor would
consider material must be "complete and
accurate." This, however, does not mean that
by revealing one fact about a product, one
must reveal all others that, too, would be
interesting, market-wise, but means only
such others, if any, that are needed so that
what was revealed would not be "so
incomplete as to mislead."
SEC v. Texas Gulf Sulphur Co., 401 F.2d 833,
862 (2d Cir.1968), cert. denied, 394
U.S. 976, 89 S.Ct. 1454, 22 L.Ed.2d 756
(1969). Disclosing that Polavision was being
sold below cost was not misleading by reason
of not saying how much below. Nor was it
misleading not to report the number of
sales, or that they were below expectations.
Plaintiffs do make a contention
that, if correct, would trouble us. In their
brief they say,
[B]y late October 1978 Polaroid knew that
Polavision was a commercial failure.
Polaroid had begun marketing the product to
dealers below cost.... Sales nonetheless
continued significantly under plan.
We could agree that if management
knew at the time of the report that
Polavision was a commercial failure, to say
simply that its earnings were negative might
well be found to be a material
misrepresentation by half-truth and
incompleteness. Plaintiffs' own recital,
however, was not even a half-truth.
Defendant had not "begun" selling below cost
"by late October" (in spite of which sales
continued to fall below estimate).
Polavision's earnings had been negative, and
so reported, in the Second Quarter Report to
Shareholders. But, far more serious, on the
uncontradicted evidence defendant did not,
at any material time, know that Polavision
was a commercial failure. 5
The most convinced of all of eventual
success, and the most significant, was Dr.
Land. The only difference in internal
opinion was that some of defendant's
officers contemplated a smaller number of
sales than did others, but none thought
there would be failure. On this record, we
find it incomprehensible that plaintiffs
could make a statement so far from the
truth.
We come, next, to the January 9
Rowland Foundation sale release. There was
nothing untrue or misleading in the release
itself, but plaintiffs say, with support
from the panel opinion, that it should have
contained additional information in order to
keep the November report from being
misleading. We turn to this broad matter
that has interested the amici.
2. Duty to Update
Obviously, if a disclosure is in
fact misleading when made, and the speaker
Page 17 thereafter learns of this, there is a duty
to correct it.
Greenfield v. Heublein, Inc., 742 F.2d 751,
758 (3d Cir.1984), cert. denied, 469
U.S. 1215, 105 S.Ct. 1189, 84 L.Ed.2d 336
(1985), cited by the panel, the court called
for disclosure if a prior disclosure
"becomes materially misleading in light of
subsequent events," a quite different duty.
We may agree that, in special circumstances,
a statement, correct at the time, may have a
forward intent and connotation upon which
parties may be expected to rely. If this is
a clear meaning, and there is a change,
correction, more exactly, further
disclosure, may be called for.
In re Phillips,
881 F.2d 1236 (3d Cir.1989);
Wilson v. Comtech Telecommunications Corp.,
648 F.2d 88 (2d Cir.1981). The amici are
concerned that this is a principle with
grave dangers of abuse. Fear that statements
of historical fact might be claimed to fall
within it, could inhibit disclosures
altogether. And what is the limit? In the
present case if the shoe were on the other
foot, and defendant could have, and had,
announced continued Polavision profits, for
how long would it have been under a duty of
disclosure if the tide turned? Plaintiffs'
contention that it would be a jury question
is scarcely reassuring.
We do not, however, face this
question. The panel opinion was a mixed
marriage of a duty to update and outright
rejection of Roeder. After indicating
reluctance to accept plaintiffs' contention
that the Third Quarter Report was misleading
when made, the panel opinion, in holding
that it could be found misleading in light
of later developments, said as follows.
[E]ven if the optimistic Third Quarter
Report was not misleading at the time of its
issuance, there is sufficient evidence to
support a jury's determination that the
report's relatively brief mention of
Polavision difficulties became misleading in
light of the subsequent information acquired
by Polaroid indicating the seriousness of
Polavision's problems. This subsequent
information included ... Polaroid's decision
to ... stop Polavision production by its
Austrian manufacturer, Eumig, and its
instruction to its Austrian supplier to keep
this production cutback secret. We feel that
a reasonable jury could conclude that this
subsequent information rendered the Third
Quarter Report's brief mention of Polavision
expenses misleading, triggering a duty to
disclose on the part of Polaroid. (Emphasis
in orig.)
At the time of the Rowland sale,
while selling the stock had absolutely
nothing to do with Polaroid's financial
health.... some might find it less than
forthcoming for the press release not to
have at least mentioned Polavision's
difficulties so that the investing public
could assess for themselves the reasons
behind the sale.
That this was an improper mix was
made conspicuous by plaintiffs' oral
argument.
[W]e've cited the specific passages of
Mr. McCune's testimony in our brief, where
Mr. McCune testified that the expression,
"continued to reflect substantial expenses"
was intended to convey that that condition
would continue in the future.
. . . . .
What we're saying is that a jury could
find that this statement, even if it wasn't
misleading when issued, became misleading
because of the forward-looking nature.
This is a failure to recognize
that what Mr. McCune said was a single,
simple, statement, that substantial expenses
had made Polavision's earnings negative.
Though the panel opinion characterized it as
"relatively brief," it was precisely
correct, initially. Even if forward-looking,
it remained precisely correct thereafter.
Plaintiffs' claim, "The statement was
plainly intended to survive the date of
issuance, and therefore a jury could
reasonably find a duty to update and correct
exists," means nothing, unless "update"
means something more than "correct." And,
indeed, in arguing that the statement did
not "remain true," plaintiffs' brief,
unabashedly, points solely to matters
outside the scope of the initial disclosure,
in no way making it incorrect or misleading,
originally, or later.
The shell in plaintiffs' gun at
trial, and the one substituted on appeal,
are all percussion
Page 18 cap and no powder. We understand the amici
apprehension because of the panel opinion's
not only requiring update, but requiring it
in terms of a new duty that had never been
undertaken. With those errors corrected,
however, we see no reason to proceed
further. Plaintiffs have no case.
This decision moots plaintiffs'
appeal on the subject of interest.
The court's denial of judgment
for defendant n.o.v. is reversed, with costs
in this court, and the cause is remanded for
dismissal of the complaint, with costs in
the district court.
BOWNES, Senior Circuit Judge,
dissenting.
At the outset I think it
necessary to state what this case is not
about. This case is not about the extent to
which our opinions do or do not "command
response." Nor is it about the happy or
unhappy performance of counsel, the lower
court, or even the panel whose opinion has
now been withdrawn by the full court.
Rather, the case presents important issues
concerning, inter alia, the scope of a
corporation's disclosure duties under
federal securities law as well as the
province of the jury in making factual
determinations in securities litigation.
With respect, I not only disagree with the
majority's resolution of certain of these
issues, but I also believe that the issues
merit more extended discussion than the
majority has accorded them. I begin with an
exposition of the pertinent facts.
Polaroid is a manufacturer of
instant photographic and light polarizing
products based in Cambridge, Massachusetts.
In the spring of 1978, Polaroid began
national sales of its much-heralded instant
motion picture system, Polavision. Polaroid
introduced Polavision with a multi-million
dollar advertising campaign in March, 1978,
and as of that time, projected worldwide
sales of 200,000 units in 1978.
The facts that form the heart of
this dispute began with the issuance of
Polaroid's Third Quarter Report to
Stockholders on November 5, 1978. The bulk
of that report spoke in glowing terms of the
successful year Polaroid was having in 1978.
Fueled by instant camera and film sales,
Polaroid was posting record earnings in
1978, and its Third Quarter Report
emphasized Polaroid's booming sales and
record manufacturing output. One brief
statement in this report, however,
acknowledged that Polaroid's earnings
"continue to reflect substantial expenses
associated with Polavision." Two other
statements observed that Polaroid's cost of
sales had increased due, in part, to these
same Polavision expenses.
The "substantial expenses"
resulted from Polavision sales that were
well below initial projections. The lower
than expected sales caused Polaroid, in
October, 1978, to instruct its Austrian
supplier, Eumig, first to reduce its
production of Polavision units, and then in
November, 1978, to cease production
entirely, at least until excess inventory
was depleted. Polaroid also requested that
Eumig keep information about the production
cut secret from the public.
The effect of these low
Polavision sales on earnings began to be
quantified, albeit tentatively, as early as
December, 1978. On December 4, 1978, an
internal Polaroid reporting document
entitled Forecast 11 was circulated to the
Management Executive Committee. The report
was based on 10 months actual sales and a
forecast for November and December. In
Forecast 11, the Polavision sales projection
for 1978 dropped to 97,000 units, down from
100,000 projected in October and the 200,000
projected in February. Also, the preliminary
earnings estimate for the fourth quarter was
calculated to be $1.37 per share, lower than
most market analysts were predicting.
The next internal report,
Forecast 12, was circulated on January 15,
1979. Forecast 12 was based on 11 months
actual sales and an estimate for December,
1978 that was calculated, in part, from
early December results. Its preliminary
earnings calculation estimated fourth
quarter earnings to have been $1.31 per
share, one cent less than the final, audited
figure of $1.32 per share ultimately
calculated. Forecast 12 also reflected the
need to take
Page 19 an additional reserve for Polavision
expenses in the fourth quarter. A $6.8
million reserve was taken on February 1.
At approximately the same time as
these events were occurring, the Rowland
Foundation, a charitable organization run by
Dr. Edwin Land, Polaroid's founder, decided
to sell 300,000 shares of Polaroid stock. A
draft press release announcing the sale was
given to Polaroid's in-house general counsel
on the morning of January 9 by Julius
Silver, a Polaroid vice-president and
director who also acted as attorney for the
Rowland Foundation. The press release,
printed on Rowland Foundation stationery,
was issued by Polaroid's public relations
department in the late afternoon of January
9. The release announced as one of the
reasons for the sale the desire to diversify
the Foundation's assets and free up funds
for new pursuits. It also mentioned the
impending retirement of Dr. Land as Chairman
and Chief Executive Officer of Polaroid. The
sale of stock took place on January 11, at a
price of $52 per share, for a total of $16
million.
Approximately five weeks later,
after the close of the market on February
22, 1979, Polaroid issued a press release
announcing its 1978 earnings. The release
reported a 26% earnings gain for all of
1978, and earnings per share of $1.32 in the
fourth quarter. Concerning Polavision, the
press release announced:
The Company's 1978 record earnings were
achieved notwithstanding manufacturing costs
and marketing expenses substantially in
excess of revenues from the Polavision
program. This program is expected to
continue to make significant demands on cash
and earnings in 1979. 1
The market reaction to this
release was quite pronounced. Between
February 22 and March 1, the price of
Polaroid's common stock dropped from $49.625
to $39.875, a difference of $9.75. It then
stabilized at this level.
The named plaintiffs represent
two certified classes of persons who
purchased (1) Polaroid common stock or (2)
call options on Polaroid common stock during
the period January 11, 1979 through February
22, 1979 (the "Class Period"), and who held
such securities as of the close of trading
on February 22, 1979. Plaintiffs allege that
the market price of Polaroid securities was
artificially inflated during the class
period as a result of Polaroid's violation
of Section 10(b) of the Securities Exchange
Act of 1934 and Rule 10b-5 promulgated
thereunder. 2
Specifically, plaintiffs claim that Polaroid
knowingly or recklessly breached a duty to
disclose adverse material facts concerning
sales difficulties with Polavision; that
Polaroid's failure to disclose these facts
artificially inflated the price of Polaroid
securities; and that plaintiffs, having
relied on Polaroid's conduct, consequently
suffered damages when the information
eventually was released and resulted in a
sharp decline in the price of Polaroid's
securities.
At the liability phase of the
bifurcated trial, Polaroid moved for a
directed verdict after the close of
plaintiffs' presentation. This motion was
denied. The jury returned a verdict in favor
of the plaintiffs and answered special
interrogatories finding that Polaroid had
knowingly or recklessly breached a duty to
disclose material adverse facts known to it
prior to January 11, 1979, and that
plaintiffs had suffered a loss causally
related to Polaroid's conduct. After
Page 20 the trial on damages, the jury found that
for each day of the class period, the price
of Polaroid common stock was inflated by
$9.75 above its true value. The trial judge
entered judgment accordingly, and denied
Polaroid's motions for judgment n.o.v. or,
alternatively, for a new trial.
Polaroid appealed, claiming that
the trial judge had committed reversible
error in his instructions to the jury on
each of the legal elements of securities
fraud and that there was insufficient
evidence as a matter of law to support the
jury's verdict. A divided panel of this
court agreed with Polaroid that certain jury
instructions had been flawed and vacated the
judgment on that basis. The panel concluded,
however, that sufficient evidence existed to
support the plaintiffs' case and remanded
for a new trial.
One of the crucial issues before
the panel concerned the sufficiency of the
evidence to support the plaintiffs' claim
that Polaroid had a duty to disclose adverse
information regarding Polavision's
difficulties. Plaintiffs based their
allegations regarding the existence of a
duty on three grounds. First, plaintiffs
claimed that Polaroid's Third Quarter Report
was misleading because Polaroid had buried
an extremely brief mention of Polavision
expenses within an otherwise glowing summary
of 1978 earnings to date. Plaintiffs argued
that the Report's failure to contain more
concrete information regarding Polavision's
difficulties was misleading, and triggered a
duty to disclose adverse facts. Second,
plaintiffs alleged that information compiled
by Polaroid after November 5, including
increasingly negative reports regarding
Polavision sales as well as reasonably
certain preliminary calculations of lower
than expected fourth quarter earnings
(Forecasts 11 and 12), constituted adverse
material facts that Polaroid was under a
duty to disclose to prevent its optimistic
Third Quarter Report from being misleading.
Finally, plaintiffs claimed that Polaroid
was intricately involved with the press
release announcing the Rowland Foundation's
sale of stock and that it was materially
misleading for Polaroid not to include in
that press release some mention of the
difficulties with Polavision. Plaintiffs
argued that this conduct on the part of
Polaroid constituted a knowing or reckless
breach of a duty to disclose material
adverse facts that resulted in harm to the
plaintiffs when the adverse information
became known and triggered a sharp decline
in the price of Polaroid securities.
Of these three possible bases
advanced by the plaintiffs to support a duty
to disclose, the panel expressed
reservations about the sufficiency of the
evidence to support theories one and three,
but reserved judgment on them. The panel did
rule, however, that a properly instructed
jury could base a duty to disclose on theory
two. Specifically, the panel stated: "even
if the optimistic Third Quarter Report was
not misleading at the time of its issuance,
there is sufficient evidence to support a
jury's determination that the report's
relatively brief mention of Polavision
difficulties became misleading in light of
the subsequent information acquired by
Polaroid indicating the seriousness of
Polavision's problems." (Emphasis in
original).
Polaroid petitioned for a
rehearing before the full court. The
petition was granted to consider whether the
panel's ruling with respect to plaintiffs'
second theory erroneously created an overly
broad "duty to update" on the part of
Polaroid, and, if so, whether overturning
the panel on this ground required entry of
judgment in favor of Polaroid. The majority
of the court has answered both questions in
the affirmative. I respectfully disagree.
I. DUTY TO DISCLOSE
Roeder
v. Alpha Industries, Inc.,
814 F.2d 22 (1st
Cir.1987), this court identified three
situations that could trigger a duty to
disclose: (1) when a "corporate insider
trades on confidential information," (2)
when a corporation has made "inaccurate,
incomplete, or misleading prior
disclosures," and (3) when a statute or
regulation requires disclosure. Id. at
26-27;
Staffin v. Greenberg, 672 F.2d 1196, 1203-04
(3d Cir.1982) (identifying insider
trading and misleading statements as the two
contexts
Page 21 that trigger a duty to disclose). Roeder
stated further that:
The materiality of the information
claimed not to have been disclosed, however,
is not enough to make out a sustainable
claim of securities fraud. Even if
information is material, there is no
liability under Rule 10b-5 unless there was
a duty to disclose it.
Roeder, 814 F.2d at 26;
Basic, Inc. v. Levinson, 485 U.S. 224, 239
n. 17, 108 S.Ct. 978, 987 n. 17, 99 L.Ed.2d
194 (1988) ("Silence, absent a duty to
disclose, is not misleading under Rule
10b-5");
Chiarella v. United States,
445 U.S. 222, 235, 100 S.Ct. 1108, 1118, 63 L.Ed.2d 348
(1980);
Starkman v. Marathon Oil Co.,
772 F.2d 231, 238 (6th Cir.1985) ("[T]he established
view is that a 'duty to speak' must exist
before the disclosure of material facts is
required under Rule 10b-5."), cert. denied,
475 U.S. 1015, 106 S.Ct. 1195, 89 L.Ed.2d
310 (1986).
Invoking the second factor
articulated in Roeder, the panel opinion
stated that a duty to disclose could arise
if a company possessed material facts that
must be released in order to render prior
statements not misleading. The panel held
that sufficient evidence existed in the
record to support the existence of a
disclosure obligation on the part of
Polaroid under this theory, and accordingly
remanded for a new trial.
Polaroid challenges the panel's
disclosure theory as an unwise extension of
Roeder. At the heart of this challenge is a
distinction that Polaroid draws between a
corporation's duty to correct prior
statements, and a corporation's duty to
update prior statements. Polaroid appears to
concede that in two types of situations
corporations may have a duty to disclose
information in order to correct prior
statements. First, there is a duty to
correct prior statements that were
inaccurate or misleading when they were
made. See, e.g., Roeder, 814 F.2d at 26-27.
Second, there can be a duty to correct prior
statements of a forward-looking or
predictive nature that, although perhaps
true when made, have become misleading due
to subsequent events. 3
See, e.g.,
In re Phillips Petroleum Securities
Litigation, 881 F.2d 1236, 1245 (3d
Cir.1989) ("There can be no doubt that a
duty exists to correct prior statements, if
the prior statements were true when made but
misleading if left unrevised.");
Greenfield v. Heublein, Inc., 742 F.2d 751,
758 (3d Cir.1984), cert. denied, 469
U.S. 1215, 105 S.Ct. 1189, 84 L.Ed.2d 336
(1985); Ross v. A.H. Robins Co., 465 F.Supp.
904, 908 (S.D.N.Y.) ("It is now clear that
there is a duty to correct or revise a prior
statement which was accurate when made but
which has become misleading due to
subsequent events. This duty exists so long
as prior statements remain 'alive'."), rev'd
on other grounds,
607 F.2d 545 (2d
Cir.1979), cert. denied, 446 U.S. 946, 100
S.Ct. 2175, 64 L.Ed.2d 802 (1980). Polaroid
contends, however, that corporations have no
duty to update statements of past historical
fact that were accurate when made but that
have simply become stale with the passage of
time. It argues that the panel opinion
unwisely created such a duty to update and
that this poses an impossible dilemma for
companies in trying to determine their
disclosure obligations.
Upon reconsideration, I am
persuaded that certain language in the panel
opinion, when construed in the factual
context of this case, could be interpreted
as creating an overly broad duty on the part
of corporations to update even accurate
statements of past historical fact. To the
extent the en banc majority curtails this
language, I concur. 4
Even with a narrower view of
Page 22 corporate disclosure obligations, however, I
am convinced that there is still sufficient
evidence to warrant sending this case back
for a new trial.
II. MATERIALLY MISLEADING STATEMENTS
Under the disclosure standard
articulated in Roeder, 814 F.2d at 26-27, if
Polaroid uttered misleading statements in
its Third Quarter Report, or if Polaroid
failed to reveal in the Report information
necessary to make other statements not
misleading, such conduct would trigger a
duty to disclose. For the reasons that
follow, I believe sufficient evidence exists
to require remanding this case for a
properly instructed jury to determine
whether the Third Quarter Report was
misleading in this sense at the time of its
issuance. 5
Plaintiffs' argument with respect
to the misleading nature of the Third
Quarter Report rests in large part on the
claim that the Report's optimistic
discussion of 1978 earnings, together with
its failure to contain more than but a brief
mention of Polavision expenses, created a
misleading impression with respect to the
financial health of Polavision and of
Polaroid. 6
Examination of the Report and of other
evidence in the record provides some measure
of support for the plaintiffs' claim.
There can be little dispute that
the overall tone of the Third Quarter Report
was abundantly optimistic. The Report stated
that Polaroid's "worldwide manufacturing
facilities continue to operate at close to
maximum capacity." It also spoke of "record
worldwide sales and earnings for both the
third quarter and the first nine months of
1978" and referred to the construction of
new plants to house expanded manufacturing
facilities. Finally, the Report featured a
picture of Polavision on its front cover,
supporting the inference that the optimism
expressed in the report extended to
Polavision as well.
Yet, the record furnishes support
for plaintiffs' contention that none of
these statements reflected the true status
of Polavision. In an October 31 telex,
Eumig, Polaroid's Austrian manufacturer of
Polavision units, confirmed that Polaroid
had asked it to cut back Polavision
production by 110,000 units. In a November
14 telex, Eumig subsequently confirmed that
Polaroid had instructed it to cease
Polavision production entirely. Even though
this last
Page 23 telex was not sent by Eumig until after
November 5, a jury reasonably could infer
that Polaroid must have been in the process
of making this decision prior to November 5.
This evidence would support an
inference that Polaroid had assembled
sufficient information prior to the issuance
of the November 5 quarterly report to know
that there were significant problems in
Polavision sales. Certainly, the Third
Quarter Report's statement about
manufacturing facilities operating at close
to maximum capacity was not true as to
Polavision. Nor were the statements
concerning record sales or expanding
manufacturing facilities accurate as to
Polavision.
Despite these indications of
serious difficulties in Polavision sales,
the Third Quarter Report's only mention of
Polavision consisted of three scattered
references to the fact that earnings and
cost of sales continued to reflect
"substantial expenses associated with
Polavision." The majority focuses on these
references and holds that no reasonable jury
could find the Report to be misleading
because it contained this mention of
Polavision expenses. I disagree. The
references to Polavision expenses were
brief--only one even constituted a full
sentence--and were buried in a glowingly
optimistic report about the tremendous year
that Polaroid was having. Moreover, the mere
statement that there were substantial
expenses associated with Polavision does not
convey that Polaroid was experiencing
serious difficulties in Polavision sales.
Substantial expenses are a natural part of
any new product's development, even for
products that achieve instant commercial
success. Polavision, however, was
experiencing more than simply normal
start-up expenses; Polavision was suffering
from significantly lower than expected
sales. It is this information about poor
sales that plaintiffs claim should have been
disclosed in the Third Quarter Report.
Indirect proof of the incomplete
nature of the Third Quarter Report's
disclosures is provided by Polaroid's
instructions to Eumig to keep news of the
Polavision production cutback secret. If the
Third Quarter Report's mention of Polavision
expenses truly had constituted a
substantially complete disclosure of
Polavision's difficulties, as Polaroid and
the majority seem to contend, one wonders
why Polaroid would have instructed Eumig to
keep the Polavision cutback secret. An
obvious inference that a reasonable jury
could draw is that Polaroid wanted this news
kept secret because the production cutback
constituted detrimental information with
respect to Polavision's problems that
Polaroid had not disclosed and was not yet
planning to disclose--in its Third Quarter
Report or otherwise.
The majority also bases its
rejection of plaintiffs' claim on the fact
that the Third Quarter Report was literally
accurate in what it stated. Thus, with
respect to plaintiffs' contention that it
was misleading as to Polavision for the
Report to state that "worldwide
manufacturing facilities continue to operate
at close to maximum capacity," the majority
observes that "the statement, taken as a
whole, was true; it expressly recognized an
absence of totality."
Surely, however, it cannot be
enough that a disclosure simply is literally
accurate in what it says. Well-trained
lawyers will always be able to craft
literally accurate statements. Rather, the
context in which a disclosure appears must
be considered as crucial in any
determination as to whether the disclosure
is adequate or misleading. The nuances of
what a disclosure emphasizes versus what it
glosses over can render even a factually
accurate disclosure misleading in an overall
sense. See, e.g.,
Isquith v. Middle South Utilities, Inc., 847
F.2d 186, 201-03 (5th Cir.), cert.
denied, 488 U.S. 926, 109 S.Ct. 310, 102
L.Ed.2d 329 (1988);
Greenapple v. Detroit Edison Co., 618 F.2d
198, 205, 210 (2d Cir.1980). Phrased
another way, disclosures not only must be
literally accurate but they also must be
"complete enough so as not to be
misleading."
Staffin v. Greenberg, 672 F.2d at 1204;
Elkind v. Liggett & Myers, Inc., 635 F.2d
156, 164 (2d Cir.1980) (acknowledging
that even if there were no statement of an
untrue fact, a company's issuance of rosy,
optimistic statements
Page 24 could be deemed misleading if internal
company reports were less optimistic).
For many of the same reasons as
previously articulated, I believe that
sufficient evidence exists to support a
reasonable jury's conclusion that Polaroid's
Third Quarter Report failed to be complete
enough so as not to be misleading. Although
the Report clearly was drafted carefully so
as to be literally accurate in what it
stated, the Report failed to disclose
certain concrete information regarding
Polavision's difficulties. In particular,
the Report contained no mention of either
the lower than expected Polavision sales or
the cutback in Polavision production at
Eumig.
I fully acknowledge that these
alleged nondisclosures are not so egregious
as to constitute an overwhelming case
against Polaroid. 7
Indeed, the majority persuasively has
countered many of the plaintiffs'
contentions. Regardless of whether I agree
with the majority on the underlying merits,
however, that is not the issue before us.
The applicable standard does not require
that plaintiffs have a substantial
likelihood of success in order to get their
case to the jury. Rather, our role is
strictly limited to determining whether
there is sufficient evidence so that a
properly instructed jury could reasonably
find for the plaintiffs. See, e.g.,
Fact Concerts, Inc. v. City of Newport, 626
F.2d 1060, 1064 (1st Cir.1980), vacated
on other grounds, 453 U.S. 247, 101 S.Ct.
2748, 69 L.Ed.2d 616 (1981); 5A J. Moore &
J. Lucas, Moore's Federal Practice p 50.07
(1990).
I believe that the plaintiffs in
this case have met this threshold. I concede
that it is a close question, and I recognize
why corporations may be uneasy about juries'
handling such close questions, particularly
in complex securities litigation, where
there is the potential for bias against
corporate defendants. There is more than a
hint of this concern in the majority's
opinion. Courts, however, must vigilantly
guard against any tendency to heighten the
standard required for plaintiffs to get such
cases before a jury, or they risk
undercutting the vital role of the jury in
our legal system.
I have faith that a properly
instructed jury could handle the issues
presented by this case objectively and
competently. I also believe that the
evidence is not so weak as to support the
majority's conclusion that no reasonable
jury could find for the plaintiffs.
Accordingly, I respectfully dissent.
1 E.g., "The idea [of the law] is that
there should be full disclosure so that
everyone has all of the relevant facts, that
the marketplace has the relevant facts
concerning a particular stock. And then,
being fully informed, people can make their
judgments."
2 In spite of these positive statements,
the dissent, in n. 6, maintains that
"plaintiffs' theory consistently has been
that Polaroid's failure to disclose
information misled investors." The dissent's
quotation of plaintiffs' listings of
non-disclosed facts, however, makes full
sense in terms of simple non-disclosure as
distinguished from misleading. But lest
there be doubt we note that plaintiffs
expressly requested that the jury be
instructed that their claims were other than
of being misled by untrue or incomplete
statements.
REQUEST TO CHARGE NO. 7
Explanation of Rule 10b-5
The Class' claims arise under Section
10(b) of the 1934 Act, and 10b-5 of the
Securities and Exchange Commission, which
has the force of law. Rule 10b-5 provides
that it is unlawful for any person, directly
or indirectly, in connection with the
purchase or sale of any security:
(a) to employ any device, scheme, or
artifice to defraud,
(b) to make any untrue statement of a
material fact or to omit to state a material
fact necessary in order to make the
statements made, in the light of
circumstances under which they were made,
not misleading, or
(c) to engage in any act, practice, or
course of business which operates or would
operate as a fraud or deceit upon any
person.
Plaintiffs claim that Polaroid violated
subsections (a) and (c) above during a
period of time beginning on January 11, 1979
and continuing through February 22, 1979, in
connection with the class' purchase of
Polaroid securities.
Excluding subsection (b) was not some
early, abandoned, view. The requests were
filed on the last day of trial.
3 For example,
Did Polaroid ... know material adverse
facts concerning its business prior to
January 11, 1979?....
It is unlawful to omit to state a
material fact. A fact is material if it is
one that an investor would consider
important in deciding whether or not to
purchase stock.
4 The entire paragraph read,
Mr. McCune noted that the Company's
worldwide manufacturing facilities continue
to operate at close to maximum capacity.
Construction of a new building in Norwood,
Massachusetts, to house expanded camera
manufacturing facilities is on schedule.
"Planning is proceeding," Mr. McCune said,
"for the development of the recently
acquired site for film assembly in Andover,
Massachusetts, and film assembly expansion
continues at Polaroid's facility in
Enschede, The Netherlands." The Company has
also concluded an agreement with the
Government of Ireland, he stated, for the
construction of a new facility near Dublin
to manufacture SX-70 film and cameras as an
additional element of its program to supply
the indicated increase in worldwide demand.
5 Mr. Buckler, an executive vice
president and a member of the management
executive committee testified,
Q. Mr. Buckler, in 1978 and early January
and February 1979 was there any intent on
the part of Polaroid to abandon Polavision?
A. No, there wasn't.
Q. In 1978 and early 1979, Mr. Buckler,
did you believe Polavision could be a
commercially-successful venture for
Polaroid?
A. Yes, I did, and I was committed to it
at that time.
1 Polavision sales did not improve. Sales
continued to drop and Polavision eventually
was removed from the market.
2 Rule 10b-5 states:
It shall be unlawful for any person,
directly or indirectly, by the use of any
means or instrumentality of interstate
commerce, or of the mails or of any facility
of any national securities exchange,
(a) To employ any device, scheme, or
artifice to defraud,
(b) To make any untrue statement of a
material fact or to omit to state a material
fact necessary in order to make the
statements made, in the light of the
circumstances under which they were made,
not misleading, or
(c) To engage in any act, practice, or
course of business which operates or would
operate as a fraud or deceit upon any
person,
in connection with the purchase or sale
of any security.
17 C.F.R. Sec. 240.10b-5 (1990).
3 Determining whether a statement is of
sufficient continuing viability or possesses
a sufficiently forward-looking nature to
support a duty to disclose raises a host of
difficult questions, which are perhaps best
considered on a case-by-case basis. The
facts of this case do not require me to
address these questions. See infra n. 7. One
possible example of such a statement,
however, would be an announcement by a
company that it had just secured a major
long-term contract to provide products or
services to another party. If the contract
collapsed, for some reason, the company
arguably would have a duty to disclose this
information to prevent its prior statement,
which would still be "alive," from
misleading investors.
4 I do not, however, agree with the en
banc majority's characterization of the
panel opinion as constituting an "outright
rejection" of Roeder, an opinion that I
authored and with which I have more than a
passing acquaintance. The panel may have
extended Roeder to an extent at odds with
the full court, but it in no way rejected
Roeder. Indeed, there is language in the
panel opinion expressly reaffirming Roeder
's standard.
5 It is true that the panel opinion
expressed reservations about the sufficiency
of the evidence to support plaintiffs'
argument regarding the misleading nature of
the Third Quarter Report at the time of its
issuance. Contrary to Polaroid's
contentions, however, the panel did not
decide the matter finally. In any event, the
question is up for reconsideration along
with the other duty-to-disclose issues.
6 Polaroid contends, and the majority
appears to agree, that plaintiffs should be
barred from raising on appeal the issue of
misrepresentations or misleading conduct
because they allegedly did not present this
theory at trial. I disagree. The plaintiffs'
theory consistently has been that Polaroid's
failure to disclose information misled
investors. As part of their support for this
theory, plaintiffs introduced evidence
pertaining to information acquired by
Polaroid prior to November 5 (e.g., the
Eumig production cutback) and yet not
disclosed by Polaroid in its Third Quarter
Report or later. In his closing argument to
the jury, plaintiffs' counsel explicitly
stressed the allegedly misleading nature of
the Third Quarter Report, stating:
Now, Mr. Tolan [Polaroid's counsel]
suggested to you that the October
announcement, the third-quarter
announcement, revealed that they [Polaroid]
were having Polavision losses. Did that
announcement reveal that things were so bad
they stopped producing it? ... [Polaroid
was] bursting at the seams, and they were
telling the world, we can't produce enough
of our product. Did they tell the world that
they shut down production of Polavision,
that they laid off workers? They didn't.
Concededly, plaintiffs have emphasized
the misleading nature of the Third Quarter
Report more heavily on appeal than they did
at trial. This increased emphasis
undoubtedly is due to the plaintiffs'
accurate perception that the part of their
disclosure theory that rested on information
acquired by Polaroid after November 5 is of
questionable validity. A change in emphasis,
however, does not constitute an
objectionable alteration of a legal theory
advanced below.
7 In an effort to build a stronger case,
plaintiffs argue that the Third Quarter
Report contained forward-looking statements
sufficient to trigger a duty on the part of
Polaroid to disclose adverse information
acquired after November 5. Although a
quarterly report could, in principle,
contain such forward-looking statements, I
have found none in the Third Quarter Report.
The Report concentrated on the presentation
of information concerning Polaroid's
financial results as of November 5. Nor am I
persuaded by the plaintiffs' argument that
Polaroid's participation in the issuance of
the Rowland Foundation's press release was
sufficient to trigger a duty to disclose.
Rowland's stated reasons for selling its
Polaroid stock had absolutely nothing to do
with Polaroid's financial health. |